» Articles » PMID: 35008057

Metabolic Processes Are Differentially Regulated During Wild-Type and Attenuated Dengue Virus Infection in Aedes Aegypti

Overview
Specialty Tropical Medicine
Date 2022 Jan 10
PMID 35008057
Authors
Affiliations
Soon will be listed here.
Abstract

Successful completion of the dengue virus (DENV) life cycle in its mosquito vectors is important for efficient human-mosquito-human cycle of transmission, but the virus-mosquito interactions that underpin this critical event are poorly defined. To understand the virus-host interactions that determine viral infection by Aedes aegypti, the principal DENV vector, the authors compared transcriptomic changes in the head/thorax of the mosquito after intrathoracic infection with the wild-type DENV2 16681 strain and its attenuated derivative, PDK53. Using high-throughput RNA-sequencing, the authors identified 1,629 differentially expressed genes (DEGs) during 16681 infection, compared with only 22 DEGs identified during PDK53 infection, indicating that 16681 infection triggers a more robust host transcriptomic response compared with PDK53 infection. The authors further found that 16681 infection, but not PDK53 infection, altered metabolism in these heads/thoraces. Altogether, our findings reveal differential regulation of metabolic processes during wild-type and attenuated DENV infection, and suggest the need for future work to study the role of metabolic processes in determining DENV infection and replication in its mosquito vectors.

References
1.
Butrapet S, Huang C, Pierro D, Bhamarapravati N, Gubler D, Kinney R . Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3. J Virol. 2000; 74(7):3011-9. PMC: 111799. DOI: 10.1128/jvi.74.7.3011-3019.2000. View

2.
Choy M, Ng D, Siriphanitchakorn T, Ng W, Sundstrom K, Tan H . A Non-structural 1 Protein G53D Substitution Attenuates a Clinically Tested Live Dengue Vaccine. Cell Rep. 2020; 31(6):107617. DOI: 10.1016/j.celrep.2020.107617. View

3.
Khin M, Jirakanjanakit N, Yoksan S, Bhamarapravati N . Infection, dissemination, transmission, and biological attributes of dengue-2 PDK53 candidate vaccine virus after oral infection in Aedes aegypti. Am J Trop Med Hyg. 1994; 51(6):864-9. DOI: 10.4269/ajtmh.1994.51.864. View

4.
Giraldo-Calderon G, Emrich S, MacCallum R, Maslen G, Dialynas E, Topalis P . VectorBase: an updated bioinformatics resource for invertebrate vectors and other organisms related with human diseases. Nucleic Acids Res. 2014; 43(Database issue):D707-13. PMC: 4383932. DOI: 10.1093/nar/gku1117. View

5.
Pompon J, Manuel M, Ng G, Wong B, Shan C, Manokaran G . Dengue subgenomic flaviviral RNA disrupts immunity in mosquito salivary glands to increase virus transmission. PLoS Pathog. 2017; 13(7):e1006535. PMC: 5555716. DOI: 10.1371/journal.ppat.1006535. View